TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Diversity and Composition of gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Area under plasma concentration-time curve over dosing interval (AUC[tau])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in working memory test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sensitivity of CoV-SCAN daily testing regimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of CoV-SCAN daily testing regimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early AV fistula patency loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Scapholunate (SL) Gapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Radioscaphoid (RS) Gapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Radiolunate (RL) Gapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in average daily Combined Symptoms and Medication Score (CSMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion who demonstrate no or minimal opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion who remain HIV negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatitis C cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed 25-Foot Walk (T25-FW) Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in GERD health related quality of life (GERD-HRQL) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Abstinence Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall IOI-HA score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of anatomical variants of dural sinuses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of Life via the EuroQol Group survey EQ5D
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain measurement postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline [11C]PBR28 VT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-Intralipid [11C]PBR28 VT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Baseline Functional Connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-Intralipid Functional Connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Baseline Microglial Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-Intralipid Microglial Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lund Kennedy score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with acute kidney injury after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: anxiolysis during frozen embryo transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of identified persons seeking healthcare exposed to violence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients developing new AKI or progression of AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Dehydroepiandrosterone Sulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sex Hormone Binding Globulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Free Androgen Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cumulative incidence of spinal surgery/stabilization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of women using preferred family planning method
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Pharmacokinetic parameters of RTV-boosted ATV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of RTV-boosted ATV
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants requiring invasive mechanical ventilation
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of participants requiring tocilizumab
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants dying
Endpoint domain: Mortality/survival
Primary endpoint: Quality of Recovery-15 questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in total volume of structured PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minutes per week of PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of Pedicle Screw Trajectories
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hammersmith function scale for children with spinal muscular atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck extensor endurance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Range of Motion and Flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PONV (Postoperative Nausea and Vomiting)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Visual Analogue Scale score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement of OCD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability and validity of the EQ-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lesions number and proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Length of stay of the emergency team at the point of care
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: number of married women using contraception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Cardiopulmonary exercise test (CPET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of complications, at least grade 2 severity
Endpoint domain: Adverse events/effects
Primary endpoint: Urine cotinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: European Quality of Life Five Dimension (EQ-5D) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Physician knowledge on antibiotic use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physician attitude on antibiotic use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physician practices on antibiotic use
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Reduction in C3c staining on renal biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Episodic memory performances
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percent of total cases with assigned vasopressor given
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time required to complete bowel emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Index of sagittal engagement of the patella
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Postoperative Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Level of Occipitocervical Pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: MMJ questionnaire (Muscle and Joint Measure)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Consultation Cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Consultation Time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Comprehensiveness of the Multi-Disciplinary Treatment Results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Passivity of seating of PMMA prosthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PET outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to treatment sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Difference in TBRmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Disability Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the level of nocturia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the quality of life for people with nocturia
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Self-reported Drug Effect ratings on the Drug Effect Questionnaire (DEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thromboembolic events and clinically significant bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of actionable genomic alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of baseline genomic alterations with clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preliminary treatment satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preliminary treatment credibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Success of Pulpotomy Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic Success of Pulpotomy Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Neck Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of GFH312
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to peak drug concentration (Tmax) of GFH312
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal Elimination Half Life (t1/2) of GFH312
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usage Rating Profile Intervention (URPI)-Feasibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usage Rating Profile Intervention (URPI)-Acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of cuff re-tears
Endpoint domain: Adverse events/effects
Primary endpoint: Netto protein balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Advanced fibrosis and cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Mean Red Blood Cells Lifespan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diagnosis of abdominal tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for E7386
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC (0-t): Area Under the Concentration-time Curve From Zero (Pre-dose) to Time of Last Quantifiable Concentration for E7386
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral venous pressure as a predictor of fluid responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of healthcare-associated infections (HAI)
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of model for the detection of concussion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of canals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orthostatic rate per operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stereoscopic establishment success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of RAY1225
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration of RAY1225
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis accuracy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial deformities comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in MG-ADL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy Risk Perception Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Oxford Birth Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total numbers of Enterococcus Faecalis bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in knowledge of drug allergy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vitamin D concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain intensity in the last week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross Motor Functional Classification System level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The pain questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acute cardiac effects of CAR T-cell therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Long-term cardiac remodeling effects of CAR T-cell therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Correlation of MRI findings with clinical course
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants That Prefer Nivolumab SC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported physical fitness
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of participants with a clinical outcome of CURE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of lower-risk activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of higher-risk activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of social activities
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in multifidus muscle size (cross-sectional area)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in multifidus muscle fat infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in multifidus muscle function (% thickness change)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in multifidus muscle stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of antral lesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in serum magnesium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Width of Scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Presence of a positive test for Leishmaniasis Cutaneous
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pittsburgh sleep quality index scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Epworth Sleeping Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: The Word Learning Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: The verbal Fluency Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in health-related quality of life (HR-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in parent/caregiver-reported degree of care integration
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in usability, as measured by the System Usability Scale (SUS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety as measured by clinical laboratory test, vital sign and physical examination parameters
Endpoint domain: Adverse events/effects
Primary endpoint: delta finger-to-palm, Delta-FTP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Raynaud's phenomenon visual analog scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digital ulcers visual analog scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Dose limited toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Finger to nose test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Heel shin test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Catching and throwing tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PBS (Pediatric Balance Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of TSS (Total severity score) for subjective symptoms of atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beliefs about medicine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (AE) safety information
Endpoint domain: Adverse events/effects
Primary endpoint: Airway flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Upper Limb functional scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes of IBS-SSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Motor Coordination Test (LEMCOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall Efficacy Scale-International (FES-I)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual analogue scale (VAS-100 mm) for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic postural stability test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single leg test using the Biodex Balance System SD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer or precancerous lesions detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of SARS-CoV-2 seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants with Clinically Significant Clinical Laboratory Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural assessment scale for e
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical health
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Progression of clinical disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of coronary calcifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: neutrophil polynuclear cells levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diagnosis and grading of chondral lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of Life Questionnaire The European Organisation for Research and Treatment Cancer C30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Paracetamol use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention